Learn More
OBJECTIVE To evaluate abatacept therapy in patients with non-life-threatening systemic lupus erythematosus (SLE) and polyarthritis, discoid lesions, or pleuritis and/or pericarditis. METHODS In a(More)
OBJECTIVE To evaluate the safety and efficacy of abatacept plus methotrexate (MTX) over 5 years in patients with rheumatoid arthritis. METHODS Patients were randomized to abatacept 10 or 2 mg/kg or(More)